Public offering
Prospectus of PHARMENA SA
IMPORTANT INFORMATION TO BE READ BEFORE THE PROSPECTUS
ATTENTION! Before accessing or using the Prospectus, please thoroughly read this information and the stipulation below concerning the Prospectus available on the website. Accessing the Prospectus is equivalent to undertaking to observe the following conditions with all possible modifications thereof.
The Prospectus is made available on the website in the electronic form. We would like to remind you that documents accessed via the Internet may be changed or modified during download. Therefore, the Company, members of its bodies, employees, consultants, and entities related thereto shall not be held liable for any inconsistencies between the electronic version of the Prospect accessed by you and its paper version.
We would like to remind you that you access the Prospectus on condition that you are entitled to access it according to local regulations applicable to you. Accessing the Prospectus does not authorize you to pass it to other parties.
You are hereby provided access to the Prospectus in the electronic form at your risk and you are liable for checking whether it is free from viruses and any other undesired files.
The Prospectus has been drawn up in relation to the public offer concerning 1,759,010 series D ordinary bearer shares of “PHARMENA” Spółka Akcyjna, the nominal value of PLN 0.10 each, offered under the pre-emptive rights to the current shareholders.
LEGAL STIPULATION
Please read this stipulation thoroughly. Downloading the Prospectus file shall mean that you have made a representation as specified below, that you accept restrictions defined herein, and that you confirm that you access this website from within the territory of Poland.
On 17 May 2013, the Polish Financial Supervision Authority approved the Prospectus (“Prospectus”) of “PHARMENA” SA (“Company”), drawn up in relation to the public offer concerning 1,759,010 of series D ordinary bearer shares of “PHARMENA” Spółka Akcyjna, the nominal value of PLN 0.10 each, offered under the pre-emptive rights to the current shareholders.
NThis electronic version of the Prospectus was published based upon art. 45 in conjunction with art. 47 (1) (1) of the Act of 29 July 2005 concerning public offer and conditions of introducing financial instruments to organized trade and concerning public companies. The Prospectus is the only legally binding document containing information about the Company. Investors should read the whole Prospectus thoroughly, including without limitation the information on risk factors related to investing in the Company’s shares. All investment decisions concerning these securities should be made after the analysis of the whole Prospectus with annexes thereto.
Information published on this website are not meant for publication or distribution outside Poland. Information published on this website are meant only for people having the place of residence in Poland and staying within the territory of Poland. Neither the Prospectus nor the securities described therein have been registered, approved, or notified of in any other country than Poland. The securities described in the Prospectus may not be offered or sold outside Poland (including other EU member states and the United States of America). Each investor residing or having its registered office outside Poland should acquaint himself with Polish legal regulations and legal regulations of other countries which may apply to him.
I HEREBY REPRESENT THAT I HAVE READ THE ABOVE STIPULATIONS. I REPRESENT THAT I AM A PERSON WHO MAY BE LEGALLY PROVIDED ACCESS TO THE PROSPECTUS.